CoreAge Rx vs Trava Health
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Trava Health head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 70 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Trava Health a bad call — it's best for readers considering a quarterly medication package who will obtain the complete charge, formulation and pharmacy assignment before ordering. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Trava Health |
|---|---|---|
| Brief Score | 94/100 (A) | 70/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm quarterly total Advertised $89/mo equivalent requires a quarterly package. Full payment, supplied weeks and formulation need confirmation. Full price detailsCurrent semaglutide formulation and complete quote unknown; $89/month equivalent requires a quarterly package; earlier listing: From $119/mo (starting dose, compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm quarterly total Advertised $147/mo equivalent requires a quarterly package. Full payment, supplied weeks and formulation need confirmation. Full price detailsCurrent tirzepatide formulation and complete quote unknown; $147/month equivalent requires a quarterly package; earlier listing: From $198/mo (starting dose, compounded) |
| Coverage | US only; restrictions by state, confirmed at intake | FAQ advertises all 50 states; confirm medication- and pharmacy-specific eligibility |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Trava Health: The $89 semaglutide and $147 tirzepatide figures require quarterly packages. Complete charges and formulations remain unconfirmed; older medication dates are retained.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.